Conga Announces Netflix Documentary Star and Survival Expert Chris Lemons as Its Featured Speaker at Conga Connection 2026 August 12, 2026 The Annual Event Comes to Amsterdam This October, Bringing Together European Revenue, Commercial, and Operations Leaders to Accelerate What Matters
Allegion to Attend 2026 Mizuho Industrials & Chemicals Conference August 5, 2026 Allegion plc (NYSE: ALLE) Senior Vice President and Chief Financial Officer Mike Wagnes will discuss the company’s long-term strategy at the 2026 Mizuho Industrials & Chemicals Conference on Wednesday, August 12. The conference will be held at the Mandarin Oriental in New York City. About Allegion At Allegion (NYSE: ALLE), we design and manufacture innovative [...]
Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026 July 29, 2026 Superiority data from LATA, together with OPERA findings, add to the clinical and real-world evidence base for long-acting injectable Cabenuva Six-month follow-up CLARITY data further reinforce a more favourable injection experience with long-acting cabotegravir compared with lenacapavir after a single dose; additional studies showcase high real-world adherence and a preference for Apretude among previous oral PrEP users EXTEND 4M explores a new investigational intramuscular cabotegravir formulation dosed three times a year for HIV prevention, as part of broader long-acting pipeline data
Grindr for Equality Commits to Connecting 10M to HIV Prevention by 2028 July 27, 2026 New report finds PrEP awareness is high but access is low, as global HIV funding shrinks Grindr steps up
ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026 July 21, 2026 VOGUE is the first head-to-head, randomised daily orals study comparing 2-drug regimen Dovato with 3-drug regimen Biktarvy in treatment-naïve adults living with HIV Real-world OPERA data continues to strengthen the evidence base for Cabenuva, the only complete long-acting injectable HIV treatment regimen Six-month results from the CLARITY study will report participant experience and acceptability of long-acting cabotegravir versus lenacapavir injections after a single dose in HIV-negative adults
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership June 26, 2026 Receives AI Governance & Risk Excellence Award at OpenAI Partner Summit Capco’s UK AI Lab wins OpenAI Codex Hackathon
One in Three Western Consumers Now Buy Products Discovered on Social Platforms as AI Reshapes Commerce, According to NIQ June 26, 2026 New insights presented at The Consumer Goods Forum Global Summit highlight how AI is accelerating the convergence of global commerce models—reshaping growth strategies for brands and retailers
ISC2026: KAYTUS Launches Gigawatt-Scale Prefabricated AI Factory Data Center June 25, 2026 End-to-end single-vendor delivery in as little as six months, scaling from 3MW to 1GW with a fully factory-prefabricated modular solution spanning IT, power, and cooling infrastructure
New Research Shows Prioritisation of Digital Twins and AI Initiatives to Accelerate Predictive Insights and Infrastructure Resilience June 24, 2026 Nearly two thirds of infrastructure organisations cite disconnected systems as barriers to achieving resilience goals, and look to digital twins to unify fragmented data
Beyond the ‘Dumb Pipe’: How Agentic AI and Sovereign Networks Are Redefining Connectivity June 23, 2026 The global connectivity market is shifting. With traditional European telecom growth slowing to 2-3% by 2029, businesses must adapt through Agentic AI, critical communications, and digital sovereignty. To remain competitive, operators should move beyond infrastructure toward an API-driven economy. These trends took center stage at Comarch User Group 2026. The conference hosted over 700 partners [...]